Contrast Injector Market - Forecasts from 2019 to 2024

June 2019 | 115 pages | ID: C80B70CF876FEN
Knowledge Sourcing Intelligence LLP

Abstracts

The contrast injector market is projected to expand at a CAGR of 7.01% to reach US$748.350 million in 2024 from US$498.483 million in 2018. Medical devices employed for injecting radio-opaque contrast media into the body to enhance the visibility of tissues for a medical imaging procedure are known as contrast injectors. Over the years, with technological advancement, these contrast injectors have evolved from manual injectors having manifolds with stop-cocks to automated versions, providing added accuracy and advantages.

The rapid growing geriatric population along with the increasing number of chronic diseases is the key factors that drive the growth of the market. Increasing adoption of minimally invasive techniques along with the increase in investment in the healthcare sector in developing economies is also considered as the key drivers for the growth of the market. Technological advancement in the contrast media injectors also fuels up the growth of the market. However high cost associated with contrast media injectors is considered as the restraining factor for the growth of the market.

By product, consumables are projected to account for a significant market share due to its use in diagnostic procedures to maintain hygiene. By geography, the Asia Pacific region is expected to have a significant growth rate during the forecast period owing to rising healthcare expenditure in the region and the growing presence of international players.

DRIVERS

• The growing geriatric population along with an increase in chronic diseases
• Technological advancement in contrast media injectors
• Increasing investments in healthcare in developing nations

RESTRAINTS

• Health concerns regarding side effects and allergies due to contrast agents

INDUSTRY UPDATE

• In November 2018, Guerbet, a global specialist in contrast agents and solutions for medical imaging, announced that the OptiVantage®multi-use injector is now CE-marked. This injector is designed for injecting contrast agents used in X-ray (CT scan) medical examinations with no compromise in efficiency and patient safety.
• As per 2016 report, Syringeless injectors, new systems for CT and MR contrast and integration with EMR/PACS for dose analytics are among the major driving forces in contrast media injector technology.

SEGMENTATION

The contrast injector market has been analyzed through the following segments:

• By product
• Injector Systems
• Consumables
• By application
• Radiology
• Intervention radiology
• Intervention cardiology
• By End Users
• Hospitals and Clinics
• Diagnostic Centers
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• Israel
• Others
• Asia Pacific
• China
• Japan
• South Korea
• India
• Others

Contents

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources

3. KEY FINDINGS

4. MARKET DYNAMICS

4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. CONTRAST INJECTOR MARKET BY PRODUCT

5.1. Injector systems
5.2. Consumables

6. CONTRAST INJECTOR MARKET BY APPLICATION

6.1. Radiology
6.2. Intervention Radiology
6.3. Intervention Cardiology

7. CONTRAST INJECTOR MARKET BY END USERS

7.1 Hospitals and clinics
7.2 Diagnostic centers

8. CONTRAST INJECTOR MARKET BY GEOGRAPHY

8.1. North America
  8.1.1. USA
  8.1.2. Canada
  8.1.3. Mexico
8.2. South America
  8.2.1. Brazil
  8.2.2. Argentina
  8.2.3. Others
8.3. Europe
  8.3.1. Germany
  8.3.2. France
  8.3.3. United Kingdom
  8.3.4. Spain
  8.3.5. Others
8.4. Middle East and Africa
  8.4.1. Saudi Arabia
  8.4.2. Israel
  8.4.3. Others
8.5. Asia Pacific
  8.5.1. China
  8.5.2. Japan
  8.5.3. South Korea
  8.5.4. India
  8.5.5. Others

9. COMPETITIVE INTELLIGENCE

9.1. Competitive Benchmarking and Analysis
9.2. Recent Investments and Deals
9.3. Strategies of Key Players

10. COMPANY PROFILES

10.1. BAYER AG
10.2. Nemoto Kyorindo Co., Ltd
10.3. Ulrich GmbH & Co. Kg.
10.4. Guerbet Group
10.5. Vivid Imaging
10.6. Apollo RT Co., Ltd.
10.7. Medtron AG
10.8. Sino Medical
10.9. Angiodynamics
10.10. Medtronic
LIST OF FIGURES
LIST OF TABLES